Personalized Medicine – News and Features

An array of nanopillars that can breach the nucleus of cells without damaging the membrane could open new possibilities in gene therapy.

Researchers developed the DRIVE method, which analyzes shared segments of the genome to identify undiagnosed cases of Long QT syndrome. The study highlights the potential for better detection of rare genetic variants in larger populations.

A new study shows that a powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable.

A UCLA team created a biobank of sarcoma organoids from 126 patients, enabling rapid drug screening. The organoids retained tumor characteristics, allowing identification of effective FDA-approved treatments for 59% of samples.

A team of researchers at the University of Southampton say they have etched the full human genome onto a 5D memory crystal, which can survive for billions of years.

A study reveals more than 3,000 genetic changes in a cancer protection gene that heightens breast and ovarian cancer risk. This research enhances risk assessment for patients, especially those with a family history of cancer.

A study shows that childhood trauma significantly impacts adult health and disease risk, with effects varying by sex. The research analyzed data from over 2,100 participants.

Single-cell analysis offers a unique perspective of the genetic and molecular features of individual cells. In this article, two early adopters of single-cell analysis technologies highlight some of the latest advances and new applications.

For non-small cell lung cancer treatment, immunotherapy poses less risk for persons under a certain BMI. At the same time, conventional chemotherapy appears optimal for persons who might be overweight or obese.

Researchers have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules measured in blood, urine and saliva samples from 391 volunteers.